These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22169787)

  • 1. Seroprevalence of rubella and immunogenicity following rubella vaccination in adolescent girls in India.
    Sharma HJ; Padbidri VS; Kapre SV; Jadhav SS; Dhere RM; Parekh SS; Dudhane AD; Shewale SD; Namjoshi GS
    J Infect Dev Ctries; 2011 Dec; 5(12):874-81. PubMed ID: 22169787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sero-surveillance to assess rubella susceptibility and assessment of immunogenicity and reactogenicity of rubella vaccine in Indian girls aged 18-24 years.
    Phalgune DS; Yervadekar RC; Sharma HJ; Dhere RM; Parekh SS; Chandak AO; Safai AA; Shewale SD
    Hum Vaccin Immunother; 2014; 10(10):2813-8. PubMed ID: 25483461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serologic status of women in an urban population in Brazil before and after rubella immunization campaign using routine screening data.
    Artimos de Oliveira S; Bastos Camacho LA; Uzeda Barreto MC; Coca Velarde LG; Siqueira MM
    J Infect Dis; 2011 Sep; 204 Suppl 2():S664-8. PubMed ID: 21954264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of rubella among women of childbearing age in Taiwan after nationwide vaccination.
    Su SB; Guo HR
    Am J Trop Med Hyg; 2002 Nov; 67(5):549-53. PubMed ID: 12479561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of rubella among Jordanian women of childbearing age.
    Jarour N; Hayajneh WA; Balbeesi A; Otoom H; Al-Shurman A; Kharabsheh S
    Vaccine; 2007 May; 25(18):3615-8. PubMed ID: 17280747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rubella control in Papua New Guinea: age-specific immunity informs strategies for introduction of rubella vaccine.
    Riddell M; Senn N; Clements CJ; Hobday L; Cowie B; Kurubi J; Kevin A; Siba P; Reeder JC; Morgan C
    Vaccine; 2012 Dec; 30(52):7506-12. PubMed ID: 23103194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination in secondary school students expedites rubella control and prevents congenital rubella syndrome.
    He H; Yan R; Tang X; Zhou Y; Deng X; Xie S
    BMC Infect Dis; 2016 Nov; 16(1):723. PubMed ID: 27899091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rubella vaccination in India: identifying broad consequences of vaccine introduction and key knowledge gaps.
    Winter AK; Pramanik S; Lessler J; Ferrari M; Grenfell BT; Metcalf CJE
    Epidemiol Infect; 2018 Jan; 146(1):65-77. PubMed ID: 29198212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rubella vaccination of unknowingly pregnant women during mass campaigns for rubella and congenital rubella syndrome elimination, the Americas 2001-2008.
    Castillo-Solórzano C; Reef SE; Morice A; Vascones N; Chevez AE; Castalia-Soares R; Torres C; Vizzotti C; Ruiz Matus C
    J Infect Dis; 2011 Sep; 204 Suppl 2():S713-7. PubMed ID: 21954271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroepidemiology of rubella in northern Greece.
    Gioula G; Diza-Mataftsi E; Alexiou-Daniel S; Kyriazopoulou-Dalaina V
    Eur J Clin Microbiol Infect Dis; 2004 Aug; 23(8):631-3. PubMed ID: 15243817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of HI antibody titer against rubella virus to determine the effect of mass vaccination in Tehran.
    Soleimanjahi H; Bamdad T; Fotouhi F; Roustai MH; Faghihzadeh S
    J Clin Virol; 2005 Oct; 34(2):153-4. PubMed ID: 16076562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological evidence of acute rubella infection among under-fives in Mwanza: a threat to increasing rates of congenital rubella syndrome in Tanzania.
    Mirambo MM; Aboud S; Mushi MF; Seugendo M; Majigo M; Groß U; Mshana SE
    Ital J Pediatr; 2016 May; 42(1):54. PubMed ID: 27225802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rubella sero-prevalence among children in Kilimanjaro region: a community based study prior to the introduction of rubella vaccine in Tanzania.
    Chotta NAS; Mgongo M; Uriyo JG; Msuya SE; Stray-Pedersen B; Stray-Pedersen A
    Ital J Pediatr; 2017 Jul; 43(1):63. PubMed ID: 28732540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rubella seroprevalence in Tunisian childbearing women two years after vaccination program introduction].
    Chaabouni M; Messadi F; Fki L; M Z; Hammami A; Karray H
    Pathol Biol (Paris); 2012 Jun; 60(3):170-3. PubMed ID: 22578467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroepidemiology study of rubella antibodies among pregnant women from seven Asian countries: evaluation of the rubella vaccination program in Taiwan.
    Tseng HF; Chang CK; Tan HF; Yang SE; Chang HW
    Vaccine; 2006 Jul; 24(29-30):5772-7. PubMed ID: 16759764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-stratified seroprevalence of measles, mumps and rubella (MMR) virus infections in Switzerland after the introduction of MMR mass vaccination.
    Matter L; Germann D; Bally F; Schopfer K
    Eur J Epidemiol; 1997 Jan; 13(1):61-6. PubMed ID: 9062781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of rubella in school girls and pregnant women.
    Karakoc GB; Altintas DU; Kilinc B; Karabay A; Mungan NO; Yilmaz M; Evliyaoglu N
    Eur J Epidemiol; 2003; 18(1):81-4. PubMed ID: 12705627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of nationwide supplementary immunization in Lao People's Democratic Republic: Population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine.
    Hachiya M; Miyano S; Mori Y; Vynnycky E; Keungsaneth P; Vongphrachanh P; Xeuatvongsa A; Sisouk T; Som-Oulay V; Khamphaphongphane B; Sengkeopaseuth B; Pathammavong C; Phounphenghak K; Kitamura T; Takeda M; Komase K
    PLoS One; 2018; 13(3):e0194931. PubMed ID: 29596472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the burden of rubella virus infection and congenital rubella syndrome through a rubella immunity assessment among pregnant women in the Democratic Republic of the Congo: Potential impact on vaccination policy.
    Alleman MM; Wannemuehler KA; Hao L; Perelygina L; Icenogle JP; Vynnycky E; Fwamba F; Edidi S; Mulumba A; Sidibe K; Reef SE
    Vaccine; 2016 Dec; 34(51):6502-6511. PubMed ID: 27866768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting rubella for elimination.
    Taneja DK; Sharma P
    Indian J Public Health; 2012; 56(4):269-72. PubMed ID: 23354136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.